Most sold healthcare stocks in Q4 2017
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2017, measured as net reductions in reported share positions from Q3 2017 into Q4 2017. Notable reductions at the top of this list include IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), MCKESSON CORP (MCK). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC | -13,798,458 | -$848.64K | 0 | 1 | 2 | 0 | 3 |
| BAX | BAXTER INTERNATIONAL INC | -5,385,767 | -$261.48K | 0 | 1 | 4 | 0 | 8 |
| PFE | PFIZER INC | -3,844,076 | $57.02K | 1 | 4 | 6 | 0 | 13 |
| MCK | MCKESSON CORP | -3,651,010 | -$542.74K | 0 | 4 | 2 | 2 | 6 |
| MRK | MERCK & CO. INC. | -3,226,525 | -$357.65K | 1 | 7 | 2 | 1 | 11 |
| EW | EDWARDS LIFESCIENCES CORP | -2,106,995 | -$218.29K | 1 | 1 | 1 | 1 | 3 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -1,613,599 | -$141.51K | 1 | 1 | 3 | 2 | 6 |
| TDOC | TELADOC HEALTH INC | -1,535,967 | -$50.46K | 0 | 1 | 1 | 0 | 2 |
| ABBV | ABBVIE INC | -1,428,803 | -$124.45K | 0 | 2 | 5 | 1 | 8 |
| PDCO | PATTERSON COS INC | -1,426,918 | -$80.39K | 0 | 0 | 3 | 1 | 3 |
| JNJ | JOHNSON & JOHNSON | -1,389,986 | $31.77K | 1 | 2 | 10 | 0 | 16 |
| HALO | HALOZYME THERAPEUTICS INC | -1,168,657 | -$4.47K | 1 | 1 | 1 | 0 | 4 |
| AMRN | AMARIN CORP PLC -ADR | -1,106,614 | -$2.73K | 0 | 0 | 1 | 0 | 1 |
| OPK | OPKO HEALTH INC | -917,500 | -$6.61K | 0 | 0 | 1 | 0 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -908,776 | -$27.98K | 1 | 0 | 2 | 0 | 3 |
| PINC | PREMIER INC-CLASS A | -742,189 | -$27.39K | 0 | 1 | 2 | 0 | 3 |
| EXEL | EXELIXIS INC | -716,700 | $1.65K | 0 | 0 | 1 | 0 | 1 |
| CTLT | CATALENT INC | -686,900 | -$25.68K | 0 | 0 | 1 | 0 | 2 |
| OSUR | ORASURE TECHNOLOGIES INC | -679,603 | -$29.86K | 0 | 0 | 1 | 0 | 1 |
| AZTA | AZENTA INC | -571,257 | -$17.41K | 0 | 0 | 1 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | -571,242 | -$3.00K | 0 | 0 | 2 | 0 | 2 |
| DHR | DANAHER CORP | -536,941 | $104.50K | 1 | 3 | 4 | 1 | 9 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -500,932 | -$53.77K | 0 | 1 | 1 | 0 | 2 |
| THC | TENET HEALTHCARE CORP | -498,613 | -$8.19K | 0 | 0 | 0 | 1 | 0 |
| SYK | STRYKER CORP | -488,760 | $48.83K | 0 | 1 | 4 | 0 | 5 |
| CNC | CENTENE CORP | -432,478 | -$37.53K | 1 | 0 | 2 | 0 | 3 |
| HUM | HUMANA INC | -418,400 | -$87.54K | 0 | 0 | 1 | 0 | 1 |
| HQY | HEALTHEQUITY INC | -324,500 | -$16.55K | 0 | 0 | 0 | 1 | 1 |
| UNH | UNITEDHEALTH GROUP INC | -298,678 | $666.78K | 1 | 1 | 13 | 0 | 15 |
| CRL | CHARLES RIVER LABORATORIES | -279,757 | -$26.21K | 0 | 1 | 2 | 0 | 3 |
| GMED | GLOBUS MEDICAL INC - A | -258,100 | -$2.88K | 0 | 0 | 1 | 0 | 1 |
| PETS | PETMED EXPRESS INC | -233,715 | $12.44K | 0 | 0 | 1 | 0 | 1 |
| SRNE | SORRENTO THERAPEUTICS INC | -233,563 | -$245 | 0 | 0 | 0 | 1 | 1 |
| CDXS | CODEXIS INC | -220,500 | -$646 | 0 | 0 | 1 | 0 | 1 |
| VREX | VAREX IMAGING CORP | -211,061 | $10.25K | 0 | 1 | 3 | 0 | 4 |
| KURA | KURA ONCOLOGY INC | -177,106 | -$2.62K | 0 | 0 | 1 | 0 | 1 |
| INVA | INNOVIVA INC | -175,643 | -$2.28K | 0 | 1 | 1 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -161,100 | -$2.82K | 0 | 0 | 1 | 0 | 1 |
| MMSI | MERIT MEDICAL SYSTEMS INC | -137,612 | -$5.83K | 0 | 0 | 0 | 1 | 0 |
| PBYI | PUMA BIOTECHNOLOGY INC | -134,600 | -$16.12K | 0 | 0 | 0 | 1 | 0 |
| MASI | MASIMO CORP | -131,300 | -$12.34K | 0 | 0 | 1 | 0 | 1 |
| SNY | SANOFI-ADR | -130,342 | -$457.97K | 0 | 0 | 4 | 0 | 6 |
| BIIB | BIOGEN INC | -116,198 | -$36.13K | 1 | 3 | 1 | 1 | 5 |
| USPH | U.S. PHYSICAL THERAPY INC | -113,700 | -$591 | 0 | 0 | 1 | 0 | 1 |
| RGEN | REPLIGEN CORP | -112,300 | -$4.40K | 0 | 0 | 1 | 0 | 1 |
| ICUI | ICU MEDICAL INC | -110,300 | -$10.47K | 0 | 0 | 1 | 0 | 1 |
| VCEL | VERICEL CORP | -104,792 | -$709 | 0 | 0 | 1 | 0 | 1 |
| RDY | DR. REDDY'S LABORATORIES-ADR | -101,800 | -$3.45K | 0 | 0 | 0 | 1 | 1 |
| LMAT | LEMAITRE VASCULAR INC | -95,600 | -$4.45K | 0 | 0 | 1 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | -91,869 | -$7.67K | 0 | 0 | 1 | 1 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2017
What are the most sold Healthcare stocks in Q4 2017?
The most sold healthcare stocks in Q4 2017 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q3 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2017?
Among the managers we track, net reductions were largest in companies such as IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2017).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.